YOLFTbeta
Monsenso AS

Monsenso AS

MONSO · CO · Healthcare / Health Information Services

0.187DKK-0.01 (-3.61%)

Price History

Full chart

Market Stats

Previous Close0.194
Open0.194
Day Range0.183 – 0.194
52-Week Range0.09 – 0.51
Volume14.86K
Market Cap24.19M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta1.09
50-Day Avg0.2819
200-Day Avg0.2199

About

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psychoeducation and cognitive behavioral therapy, medication reminders, task reminders, consultation prepration, and platform integration that allows monitor patients remotely. In addition, the company offers Monsenso app for carers. Monsenso A/S was incorporated in 2013 and is based in Frederiksberg, Denmark.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Thomas Lethenborg
  • Employees9
  • HeadquartersRosenørns Allé 31, 2., Frederiksberg, Denmark, 1970, Denmark
  • Websitehttps://www.monsenso.com

Leadership

  • Mr. Thomas LethenborgChief Executive Officer · b. 1969
  • Mr. Robert HojerChief Financial Officer
  • Ms. Nanna IversenChief Operating Officer

Financials

Income Statement

Currency: DKK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.30M5.25M6.42M7.50M8.78M9.06M7.14M6.21M9.62M11.16M8.91M
Growth (%)-+304.25%+22.40%+16.81%+17.02%+3.22%-21.19%-13.02%+54.90%+16.01%-20.22%
Cost of Revenue1.47M3.15M-617.00K497.00K815.00K2.72M2.44M3.01M5.09M6.18M5.44M
Gross Profit-174.11K2.09M7.04M7.01M7.96M6.34M4.70M3.20M4.53M4.98M3.46M
Gross Margin-13.41%39.89%109.61%93.38%90.72%70.01%65.81%51.54%47.08%44.63%38.88%
Operating Expense1.40M5.43M11.13M9.18M7.48M12.22M13.72M12.02M10.33M11.46M11.21M
Operating Income-1.57M-3.34M-4.09M-2.17M487.00K-5.87M-9.02M-8.82M-5.80M-6.48M-7.75M
Operating Margin-121.02%-63.62%-63.69%-28.96%5.55%-64.81%-126.29%-141.90%-60.26%-58.05%-86.97%
EBITDA-1.35M-2.80M-2.95M214.00K3.41M-2.29M-5.10M-4.00M-5.61M-1.99M-7.61M
EBITDA Margin-104.07%-53.38%-45.99%2.85%38.88%-25.26%-71.40%-64.33%-58.26%-17.84%-85.39%
Net Income-1.19M-2.66M-3.36M-2.09M24.00K-4.71M-8.15M-7.85M-5.36M-6.00M-7.22M
Net Income Margin-91.42%-50.73%-52.33%-27.82%0.27%-52.00%-114.14%-126.41%-55.66%-53.75%-81.03%
R&D--1.14M2.39M954.00K4.00M4.40M5.03M5.64M6.34M6.18M
R&D as % of Total Revenue--17.70%31.81%10.87%44.09%61.65%80.98%58.66%56.78%69.34%
Interest Expense-0217.00K494.00K468.00K379.00K317.00K138.00K112.00K32.00K116.00K
Interest Expense % of Total Revenue-0.00%3.38%6.58%5.33%4.18%4.44%2.22%1.16%0.29%1.30%

Balance Sheet

Currency: DKK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10.26M10.71M16.15M13.22M11.47M28.60M27.05M18.87M18.89M18.49M13.05M
Total Liabilities4.45M4.21M11.25M9.40M7.61M9.95M5.61M4.12M8.01M4.33M6.07M
Total Equity5.50M6.17M4.91M3.82M3.86M18.65M21.44M14.76M10.87M14.16M6.98M
Cash2.82M3.31M5.33M1.82M220.00K12.46M7.76M572.00K1.81M1.86M54.00K
Total Debt--4.00M4.00M3.75M-----1.84M
Net Debt-2.82M-3.31M-1.33M2.18M3.54M-12.46M-7.76M-572.00K-1.81M-1.86M1.79M

Cash Flow

Currency: DKK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--2.50M-2.50M-2.50M-210.00K2.91M-4.38M-3.39M2.55M-7.03M-1.49M
Investing Cash Flow--2.01M-2.01M-2.01M-1.01M-4.68M-11.26M-4.97M-2.79M-2.21M-2.14M
Financing Cash Flow--1.00M1.00M-383.00K14.02M10.94M1.17M1.48M9.29M1.82M
Capital Expenditure00118.00K2.02M1.08M4.68M11.26M5.00M2.79M2.32M2.14M
Free Cash Flow----4.52M-1.29M-1.78M-15.64M-8.39M-235.00K-9.36M-3.63M
FCF to OCF---180.95%615.24%-61.18%356.81%247.49%-9.21%133.04%243.62%

Key Statistics & Ratios

Market Cap24.19M
Enterprise Value28.67M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.42
Price / Book4.16
EPS-0.09
Book Value0.07
Revenue (TTM)7.07M
Gross Profit (TTM)3.26M
EBITDA-8.97M
Profit Margin-95.70%
Operating Margin-100.81%
Return on Equity-79.32%
Return on Assets-34.00%
Shares Outstanding96.75M
Shares Float59.71M
Beta1.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 11, 2024167:159
  • Mar 1, 20231534:1513
  • Nov 24, 202117:15